GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study
Continuation of GnRH analogue after ovum retrieval produces a faster decline in vascular endothelial growth factor levels and ascitis in women at risk of ovarian hyperstimulation syndrome
To access this article, please choose from the options below
J.G. has nothing to disclose. A.R. has nothing to disclose. J.A.G-V. has nothing to disclose. A. Pacheco has nothing to disclose. J.P. has nothing to disclose. A. Pellicer has nothing to disclose.
PII: S0015-0282(08)00880-7
doi:10.1016/j.fertnstert.2008.04.017
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

